{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:16:57Z","timestamp":1777195017592,"version":"3.51.4"},"reference-count":0,"publisher":"Medinews (Cardiology), Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cardiol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5837\/bjc.2026.002","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:56:41Z","timestamp":1768481801000},"source":"Crossref","is-referenced-by-count":1,"title":["SGLT2 inhibitors in frailty: a review of current evidence, and clinical recommendations"],"prefix":"10.5837","member":"3870","published-online":{"date-parts":[[2026]]},"container-title":["British Journal of Cardiology"],"original-title":[],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:56:41Z","timestamp":1768481801000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjcardio.co.uk\/2026\/01\/sglt2-inhibitors-in-frailty-a-review-of-current-evidence-and-clinical-recommendations\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":0,"URL":"https:\/\/doi.org\/10.5837\/bjc.2026.002","relation":{},"ISSN":["0969-6113"],"issn-type":[{"value":"0969-6113","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}